VISUALANT, INCORPORATED (OTCMKTS:VSUL) Files An 8-K Other Events

VISUALANT, INCORPORATED (OTCMKTS:VSUL) Files An 8-K Other Events
Item 8.01 Other Events.

Story continues below

Issuance of Twelfth Patent on ChromaID™ Technology

On April 5, 2018, Visualant, Incorporated (the “Company”), an emerging leader in next generation optical sensor technology, announced that it had received its twelfth patent relating to its ChromaID™ technology. The invention relates to the use of the Company’s ChromaID™ technology for identifying and analyzing fluids or particles suspended in the fluid. It has a wide range of potential applications in substance identification, security screening, authentication, quality control and medical diagnostics and other industrial and consumer markets.

The patent, issued by the United States Patent and Trademark Office as US Patent No. 9,869,636 B2, is entitled “Device For Evaluation Of Fluids Using Electromagnetic Energy.” A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits –


VISUALANT INC Exhibit
EX-99 2 ex_99-1.htm PRESS RELEASE OF VISUALANT,…
To view the full exhibit click here

About VISUALANT, INCORPORATED (OTCMKTS:VSUL)

Visualant, Incorporated is focused primarily on the development of ChromaID, a technology that uniquely identifies and authenticates any substance. The Company is in the process of commercializing its ChromaID technology. The Company’s ChromaID utilizes light at the photon (elementary particle of light) level through a series of emitters and detectors to generate a unique signature or fingerprint from a scan of any solid, liquid or gaseous material. This signature of reflected or transmitted light is digitized, creating a unique ChromaID signature. Each ChromaID signature consists of from hundreds to thousands of specific data points. In normal operation, a ChromaID master or reference scan is generated and stored in a database. The scan head can then scan similar materials to identify, authenticate or diagnose them by comparing the new ChromaID digital signature scan to that of the original or reference ChromaID signature or scan result.

An ad to help with our costs